FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers - FDA.gov
fda.govSubmitted by fdagov3951 in business
FDA announces pilot program for certain oncology drug products used with certain tests to help clinicians select appropriate cancer treatments for patients.